Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603-SZ) Stock Split, History Data
Working capital analysis
In terms of working capital, Shijiazhuang Yiling Pharmaceutical Co., Ltd. maintains a healthy position.
The total current assets of the company are valued at $6543745737.
This represents a growth rate of -9.794% compared to the previous year.
Breaking down the current assets, the cash and investments are worth $940512433, exhibiting a growth rate of -50.611% year-on-year.
The receivables, another significant portion of the current assets, are valued at $2734754910.
The year-on-year growth rate for receivables is 1.303%.
The inventory, which forms a critical part of the assets, is valued at $2458692034.
This represents a healthy year-on-year growth of 21.608%
On the liabilities side, the company's current liabilities total $4446701155.
This reflects a growth rate of -8.318% over the previous year, indicating the company's financial obligations are well under control.
2023
2022
2021
2020
2019
2018
Cash and investments
940.51
1904.28
995.26
1336.98
733.41
777.26
Receavebles
2734.75
2699.57
2593.08
2102.38
2765.78
2207.22
Inventory
2458.69
2021.82
1672.75
1580.35
1221.81
1175.67
Other
203.82
110.14
285.78
222.75
54.47
386.35
Total Current Assets
6543.75
7254.19
5602.13
5459.43
5068.20
4898.27
Acc Payable
2123.76
2060.78
1621.20
1188.39
506.77
389.04
Short Term Debt
1529.75
656.33
513.90
270.18
50.05
0.00
Other Current Liab
505.67
1027.28
216.26
28.33
46.20
375.62
Current Liabilities
4446.70
4850.13
2960.44
2238.88
806.43
764.66
Capital Structure
When examining the capital structure of Shijiazhuang Yiling Pharmaceutical Co., Ltd., it is clear that the company manages a robust portfolio.
The value of their total assets clocks in at $17128470785.
When juxtaposed with the previous year, this marks a growth rate of -6.128%, showcasing the company's ability to steadily grow its asset base.
Turning to liabilities, the company has total liabilities amounting to $5388589056.
Compared to the prior year, this reflects a growth rate of -11.874%.
The long-term debt forms a sizable part of these liabilities, coming in at $598731962.
Over the last year, the long-term debt has grown by 179.554%.
On the asset side, the cash and equivalent reserves are worth $1189759394.
The year-on-year growth of these reserves is 14.885%.
The company's common stock, another important asset, holds a value of $1670705376, growing at a rate of 0.000% from the previous year.
Finally, the company's retained earnings stand at $6810014756, marking a growth rate of -5.307% year-over-year.
These earnings represent the profits that Shijiazhuang Yiling Pharmaceutical Co., Ltd. has chosen to reinvest in the business rather than distribute as dividends.
Total Assets
$17,128.47
Total liabilities
$5,388,589,056.00
Long term debt
$598.73
Cash and eqv
$1,189,759,394.00
Goodwill
$114.19
Retained earnings
$6,810,014,756.00
Common stock
$360.00
Enterprise Value
$9.74
Historical dividend key summary
Shijiazhuang Yiling Pharmaceutical Co., Ltd.'s dividend per share is $0.5, showing the earnings shared with shareholders per share. It has grown by 66.667% this year, suggesting that the company is generating increased income for shareholders and expecting future earnings growth.
Years
Q1
Q2
Q3
Q4
Total
2023
0.000
0.000
0.500
0.000
0.500
2022
0.000
0.000
0.300
0.000
0.300
2021
0.000
0.000
0.714
0.000
0.714
2020
0.000
0.143
0.000
0.000
0.143
2019
0.000
0.000
0.071
0.000
0.071
2018
0.000
0.000
0.071
0.000
0.071
2017
0.000
0.071
0.000
0.000
0.071
2016
0.000
0.071
0.000
0.000
0.071
2015
0.000
0.036
0.000
0.000
0.036
2014
0.000
0.036
0.000
0.000
0.036
2013
0.000
0.036
0.000
0.000
0.036
2012
0.000
0.027
0.000
0.000
0.027
Net earnings per share (EPS)
Shijiazhuang Yiling Pharmaceutical Co., Ltd. has an EPS of $0.18, which signifies the profit allocated per share of common stock. With a growth rate of -77.816% this year, it indicates the company's increasing profitability and potential for share value growth. This trend signals robust financial performance and future potential.
Years
Q1
Q2
Q3
Q4
Total
2024
0.18
-
-
-
0.18
2023
0.72
0.24
0.0914
-0.24
0.81
2022
0.29
0.34
0.22
0.57
1.42
2021
0.4
0.17
0.16
0
0.73
2020
0.26
0.17
0.18
0.12
0.73
2019
0.17
0.0989
0.0714
0.0188
0.36
2018
0.18
0.0798
0.0643
0.0211
0.34
2017
0.13
0.0741
0.0643
0.0533
0.31
2016
0.11
0.0793
0.0786
0.0675
0.34
2015
0.0786
0.063
0.0714
0.0659
0.28
2014
0.0643
0.0637
0.11
0.0411
0.27
2013
0.0464
0.0543
0.0464
0.0139
0.16
2012
0.0536
0.0385
0.0107
0.0145
0.11
2011
0.0549
0.0802
0.11
0.11
0.35
2010
-
-
0.0852
0.0921
0.18
Brief information
Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) stock split history
Understanding the historical stock splits of Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) provides insights into its past financial decisions and investor sentiment. A stock split occurs when a company increases its share count by dividing its existing shares. The most recent split took place on July 07, 2021 with a ratio of 1.4:1. Throughout its history, the company has undergone 3 stock splits. Below, we delve deeper into this history, highlighting past financial strategies.
